USPTO Examiner OU JING RUI - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18806755Upper Limb Rehabilitation Device and Method of Its Application for SarcopeniaAugust 2024December 2024Allow510YesNo
18671186LYMPHANGIOGENESIS INDUCING DEVICEMay 2024March 2025Allow1000NoNo
18607076SYSTEMS AND METHODS FOR INTRODUCING AND MONITORING A NEGATIVE PRESSURE DEVICE FOR PROTECTING AN INTESTINAL ANASTOMOSISMarch 2024January 2025Allow1011YesNo
18390201SYSTEMS AND PROCESSES FOR INSERTING AN INTRAOCULAR LENSDecember 2023February 2025Allow1411YesNo
18544266SYSTEM AND METHOD FOR TRANSAORTIC DELIVERY OF A PROSTHETIC HEART VALVEDecember 2023February 2025Allow1411YesNo
18513858SELF-EXPANDABLE SURGICAL IMPLANT FOR CORRECTON OF CONGENITAL DIAPHRAGMATIC HERNIANovember 2023August 2024Allow901NoNo
18386585APPARATUS AND METHOD TO STOP BLEEDINGNovember 2023June 2025Abandon2020NoNo
18482428SUBCUTANEOUS DELIVERY TOOLOctober 2023April 2025Allow1820YesNo
18458360LOCK DELIVERY SYSTEMAugust 2023March 2024Allow710NoNo
18237446DELIVERY SYSTEM AID AND ASSOCIATED SYSTEMS AND METHODSAugust 2023April 2025Allow2020YesNo
18232591ULTRASONIC SURGICAL BLADESAugust 2023April 2025Allow2011NoNo
18222270Endoluminal Stent and Endoluminal Stent SystemJuly 2023June 2025Allow2320YesNo
18335589MITRAL LEAFLET TETHERINGJune 2023February 2025Allow2011NoNo
18333775SURGICAL INSTRUMENT WITH LOCKING ARTICULATION DRIVE WHEELJune 2023February 2025Allow2021YesNo
18142244MICROSTRUCTURE SOFT TISSUE GRAFTMay 2023June 2025Allow2521NoNo
18120173TELESCOPING STENTSMarch 2023February 2024Allow1110NoNo
18165268DELIVERY DEVICE FOR PROSTHETIC HEART VALVE WITH CAPSULE ADJUSTMENT DEVICEFebruary 2023February 2024Allow1210NoNo
18102310SEALING DEVICE AND DELIVERY SYSTEMJanuary 2023September 2024Allow1920YesNo
18150929DELIVERY SYSTEMS WITH TELESCOPING CAPSULES FOR DEPLOYING PROSTHETIC HEART VALVE DEVICES AND ASSOCIATED METHODSJanuary 2023February 2025Allow2531NoNo
18069369ADJUSTABLE RING STRIPPER FOR MORE EFFICIENTLY AND EFFECTIVELY REMOVING PLAQUE FROM ARTERIESDecember 2022September 2024Allow2020YesNo
18074981DUAL HELICAL COIL OPHTHALMIC SURGICAL INSTRUMENTS FOR REMOVAL OF LENS MATERIALS AND METHODS OF USEDecember 2022July 2024Abandon1911YesNo
18073014MODULAR HANDLE COMPRISING A TRIGGER WIRE ACTUATION MECHANISM FOR A PROSTHESIS DELIVERY DEVICEDecember 2022February 2024Allow1511YesNo
17987512SOFT TISSUE FIXATION REPAIR METHODS USING TISSUE AUGMENTATION CONSTRUCTSNovember 2022November 2023Allow1210YesNo
17976550TISSUE AUGMENTATION SCAFFOLDS FOR USE IN SOFT TISSUE FIXATION REPAIROctober 2022November 2023Allow1310NoNo
17893239SYSTEM AND METHOD FOR SECURING TISSUE TO BONEAugust 2022May 2024Allow2121YesNo
17882378APPARATUS AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEMAugust 2022February 2024Abandon1810NoNo
17881326Sealing Device and Delivery SystemAugust 2022April 2025Allow3241YesNo
17865733VASCULAR CLOSURE DEVICES AND METHODS PROVIDING HEMOSTATIC ENHANCEMENTJuly 2022November 2023Allow1611YesNo
17854632LAPAROSCOPIC SUTURING SYSTEMJune 2022July 2024Allow2420NoNo
17845162ADJUSTABLE RING STRIPPER FOR MORE EFFICIENTLY AND EFFECTIVELY REMOVING PLAQUE FROM ARTERIESJune 2022November 2022Allow510YesNo
17828441SURGICAL INSTRUMENT WITH FLEXIBLE SHAFT AND ACTUATION ELEMENT GUIDEMay 2022March 2024Allow2221YesNo
17750630EXCISIONAL DEVICES AND METHODSMay 2022November 2024Allow3040YesNo
17702738DEVICE FOR FACILITATING THE IMPLANTATION OF A SURGICAL MESHMarch 2022September 2024Allow3010YesNo
17673690STENT DEVICE WITH STENT COVERING HAVING PLURALITY OF BONDING AREASFebruary 2022April 2024Allow2611YesNo
17621626Endoluminal Stent and Endoluminal Stent SystemDecember 2021November 2023Abandon2221YesNo
17551156DEVICE AND METHOD FOR PERCUTANEOUSLY DELIVERING A TRICUSPID VALVEDecember 2021December 2023Allow2411NoNo
17541695LYMPHANGIOGENESIS INDUCING DEVICEDecember 2021October 2024Abandon3421YesNo
17537742TRANSSEPTAL GUIDE WIRE PUNCTURE SYSTEMNovember 2021September 2023Allow2110YesNo
17534131INTRAOCULAR LENS INSERTER CARTRIDGE WITH A TRAILING HAPTIC PROTECTION STRUCTURENovember 2021October 2024Abandon3530NoNo
17516241ANCHORS AND ANCHORING SYSTEMSNovember 2021May 2025Allow4331YesNo
17507667Surf leash tourniquet device and related methodsOctober 2021February 2023Allow1601YesNo
17492418VESSEL CLOSURE DEVICE WITH IMPROVED SAFETY AND TRACT HEMOSTASISOctober 2021April 2025Allow4241YesNo
17481639METHODS OF INTRACEREBRAL IMPLANT DELIVERYSeptember 2021January 2024Allow2810YesNo
17481070DISPOSABLE PASS THROUGH DILATOR AND METHOD OF USESeptember 2021November 2023Allow2610YesNo
17468893SURGICAL FASTENER HAVING A BASE AND A LEGSeptember 2021January 2024Abandon2811NoNo
17435013TELESCOPING STENTSAugust 2021December 2022Allow1521YesNo
17397683GASTRIC OBSTRUCTION DEVICE DEPLOYMENT ASSEMBLY AND METHODS OF DELIVERING AND DEPLOYING A GASTRIC OBSTRUCTION DEVICEAugust 2021December 2023Abandon2911NoNo
17444591Nasal Dilator and Methods of Fabricating Medical DevicesAugust 2021September 2023Abandon2601NoNo
17392373MICROSTRUCTURED SOFT TISSUE GRAFTAugust 2021May 2024Allow3311NoNo
17419553TUBE BODY CLEANING APPARATUSJune 2021May 2024Allow3521YesNo
17356125PRE-FORMED PARASTOMAL HERNIA REINFORCEMENT MESHJune 2021June 2023Allow2410YesNo
17298873PASSING TENSION MEMBER AROUND TISSUE MASSJune 2021February 2025Abandon4501NoNo
17329986SUBCUTANEOUS DELIVERY TOOLMay 2021September 2021Allow400YesNo
17325873SUBCUTANEOUS DELIVERY TOOLMay 2021September 2021Allow300YesNo
17240617GENDER-SPECIFIC MESH IMPLANT WITH BARRIER FOR INGUINAL HERNIA REPAIRApril 2021November 2021Allow610YesNo
17237349Distal End Structure of Sheath for Delivering Interventional Instrument and SheathApril 2021July 2023Allow2721YesNo
17230971SURGICAL TEXTILE WITH BARBS AND LOOPSApril 2021April 2024Allow3621YesNo
17283456EMBOLISM DEVICE AND SPRING COILS THEREOFApril 2021December 2024Abandon4501NoNo
17200075ENDOVASCULAR DELIVERY SYSTEMS WITH RADIAL ORIENTATION MECHANISMSMarch 2021June 2023Allow2721YesNo
17191297CRANIAL INSERTION PLACEMENT VERIFICATIONMarch 2021January 2023Allow2200YesNo
17249473DEVICES, TREATMENTS AND METHODS TO RESTORE TISSUE ELASTIC RECOILMarch 2021May 2025Abandon5061YesNo
17177040REINFORCED BIOLOGICAL TISSUEFebruary 2021September 2023Abandon3110NoNo
17266495OPHTHALMIC SURGICAL INSTRUMENT AND METHOD OF USEFebruary 2021January 2025Abandon4701NoNo
17167284DEGRADABLE SURGICAL STAPLES AND METHODS OF USING SAMEFebruary 2021July 2024Abandon4210NoNo
17165304SUBCUTANEOUS DELIVERY TOOLFebruary 2021May 2023Allow2810YesNo
17163758ENERGY TREATMENT TOOLFebruary 2021May 2025Allow5221YesNo
17263151COMPRESSIVE CRYO-HEMOSTATIC DEVICEJanuary 2021March 2024Allow3810YesNo
17126066APPARATUS FOR TREATING OBESITYDecember 2020November 2024Abandon4741NoNo
17124133APPARATUS AND METHOD TO STOP BLEEDINGDecember 2020November 2023Abandon3521YesNo
16973571PERCUTANEOUS VASCULAR ANASTOMOSISDecember 2020October 2023Allow3411YesNo
16952547MEDICAL DEVICE INCLUDING ATTACHABLE COMPONENTSNovember 2020May 2023Abandon3011NoNo
17097194STENT DELIVERY WITH EXPANSION ASSISTING DELIVERY WIRENovember 2020March 2024Abandon4001NoNo
17054295LUMINAL APPOSITION DEVICESNovember 2020January 2024Abandon3811NoNo
17090601FIXATION DEVICES, SYSTEMS AND METHODS FOR ENGAGING TISSUENovember 2020March 2024Abandon4010NoNo
17083268DUAL HELICAL COIL OPHTHALMIC SURGICAL INSTRUMENTS FOR REMOVAL OF LENS MATERIALS AND METHODS OF USEOctober 2020September 2022Allow2311NoNo
17080555ALIGNMENT AND ATTACHMENT SYSTEMS FOR MEDICAL INSTRUMENTSOctober 2020March 2025Allow5231YesNo
17080823DEVICE FOR VISIBLE PUNCTUREOctober 2020January 2024Allow3910YesNo
17034746SEALING DEVICE AND DELIVERY SYSTEMSeptember 2020April 2024Allow4341NoNo
17029681METHODS AND DEVICES FOR ACTUATING SURGICAL INSTRUMENTSSeptember 2020January 2024Allow4011YesNo
17024667DELIVERY SYSTEMS FOR CARDIAC VALVE DEVICES, AND ASSOCIATED METHODS OF OPERATIONSeptember 2020March 2025Allow5421YesNo
17013085EYE SURGERY SURGICAL SYSTEM AND COMPUTER IMPLEMENTED METHOD FOR PROVIDING THE POSITION OF AT LEAST ONE TROCAR POINTSeptember 2020January 2025Allow5321YesNo
17005262APPARATUS AND METHOD TO STOP BLEEDINGAugust 2020October 2022Allow2611YesNo
16976031SYSTEM FOR DEPLOYING A VASCULAR PROSTHESIS FOR BYPASS SURGERYAugust 2020May 2023Abandon3220YesNo
16975612ADJUSTABLE SUTURE LOCKING APPARATUSAugust 2020January 2024Allow4111NoNo
17000688SUBCUTANEOUS DELIVERY TOOLAugust 2020August 2023Allow3620YesNo
16969348DILATION PARAMETER DETERMINATION METHOD AND SYSTEM, COMPUTER AND STORAGE MEDIUMAugust 2020April 2024Abandon4401NoNo
16944365DELIVERY DEVICE FOR PROSTHETIC HEART VALVE WITH CAPSULE ADJUSTMENT DEVICEJuly 2020October 2022Allow2611YesNo
16940132CONNECTION SYSTEM FOR THE DETACHABLE FIXATION OF A HOLLOW CYLINDRICAL COMPONENT AT A RECESSJuly 2020February 2024Abandon4341YesNo
16964922DELIVERY PLATFORMS, DEVICES, AND METHODS FOR TRICUSPID VALVE REPAIRJuly 2020December 2021Allow1641YesNo
16963789Sutureless Graft Anastomotic Quick Connect SystemJuly 2020November 2023Allow3921YesNo
16929522EXCISIONAL DEVICES AND METHODSJuly 2020September 2022Allow2611YesNo
16923850PURSE STRING SUTURE INSTRUMENTJuly 2020January 2023Allow3121YesNo
16919286SURGICAL INSTRUMENT WITH LOCKING ARTICULATION DRIVE WHEELJuly 2020March 2023Allow3221YesNo
16914663ISOLATED STENTING WITH DISTAL BALLOONJune 2020April 2025Abandon5831NoNo
16904084THROUGH-THE-SHEATH TRANS-RADIAL CLOSURE DEVICE, DEPLOYMENT APPARATUS, AND METHOD OF DEPLOYMENTJune 2020December 2022Abandon3010NoNo
16900975POST-IMPLANTATION TENSIONING IN CARDIAC IMPLANTSJune 2020December 2022Abandon3001NoNo
16870012DELIVERY SYSTEMS WITH TELESCOPING CAPSULES FOR DEPLOYING PROSTHETIC HEART VALVE DEVICES AND ASSOCIATED METHODSMay 2020September 2022Allow2811YesNo
16862531MICROSTRUCTURE SOFT TISSUE GRAFTApril 2020January 2023Allow3321YesNo
16853205METHODS AND SYSTEMS FOR TREATMENT OF ANEURYSMSApril 2020June 2022Allow2620YesNo
16832534APPARATUS AND METHOD FOR PUNCTURING THE EPIDERMIS WITH CONTROLLED FLUID DELIVERYMarch 2020August 2022Allow2911YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner OU, JING RUI.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
7
(87.5%)
Examiner Reversed
1
(12.5%)
Reversal Percentile
23.9%
Lower than average

What This Means

With a 12.5% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
30
Allowed After Appeal Filing
11
(36.7%)
Not Allowed After Appeal Filing
19
(63.3%)
Filing Benefit Percentile
57.8%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 36.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner OU, JING RUI - Prosecution Strategy Guide

Executive Summary

Examiner OU, JING RUI works in Art Unit 3771 and has examined 312 patent applications in our dataset. With an allowance rate of 64.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner OU, JING RUI's allowance rate of 64.7% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by OU, JING RUI receive 2.73 office actions before reaching final disposition. This places the examiner in the 91% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by OU, JING RUI is 39 months. This places the examiner in the 11% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +54.1% benefit to allowance rate for applications examined by OU, JING RUI. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 17.4% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 23.7% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 36% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 52.1% are granted (fully or in part). This grant rate is in the 65% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.3% of allowed cases (in the 55% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.0% of allowed cases (in the 65% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.